ImmunityBio Inc. Common Stock vs PBF Energy Inc. Class A Common Stock — how do they compare? ImmunityBio Inc. Common Stock trades at $10.55 (market cap $10.51B), while PBF Energy Inc. Class A Common Stock trades at $84.5 (market cap $10.59B). The key difference: ImmunityBio Inc. Common Stock and PBF Energy Inc. Class A Common Stock are close in size by market cap, and PBF Energy Inc. Class A Common Stock pays a 1.23% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 1 Days and PBF Energy Inc. Class A Common Stock for 0 Days on average.
| IBRX | PBF | |
|---|---|---|
Market Cap | $10.51B | $10.59B |
Volume | 10,445,785 | 3,004,875 |
Sector | Health | Energy |
52-Week High | $11.55 | $89.34 |
52-Week Low | $1.98 | $26.02 |
Typical Hold Time | 1 Days | 0 Days |
Enterprise Value | $10.97B | $12.21B |
Dividend Yield | — | 1.23% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →PBF Energy refines and markets petroleum products, including gasoline, diesel, and jet fuel. It also operates logistics assets supporting its refining business.
Read more on PBF →